60 Degrees Pharmaceuticals logo

60 Degrees Pharmaceuticals

SXTP | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.03 (-5.39%)
At close: Nov 16, 2026, 4:00 PM ET
$0.51
+$0.02 (+4.35%)
After-hours: Nov 16, 2026, 7:33 PM ET
-5.39%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
38.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #578/1021 (Top 57%)

Key Statistics

Market Data

Market Cap $1.74M
1D Range
0.46 0.51
52W Range
0.46 5.20

Valuation (TTM)

PE -0.08
PB 0.66
EV/EBITDA -0.11

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $13.85
Loading financial charts...

Profile

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United Stat...

Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Jul 12, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 16, 2026
EPS
-$0.75
Miss -22.95%
REV
$233.24K
Miss -13.62%
Next Earnings
Mar 26, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$13.85
Upside
+2726.53%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.